Publications by authors named "Traber-Walker N"

Article Synopsis
  • The clinical high-risk (CHR) state for psychosis shows a lot of variability among individuals, causing challenges in treatment and research, especially since basic symptoms have often been overlooked.
  • The study assessed 875 patients from early intervention centers in Germany and Switzerland, using specific diagnostic tools to categorize their symptoms and demographics.
  • Results led to identifying three distinct clinical profiles: one with low symptom probability and high functioning, another with high basic and positive symptoms but low functioning, and a third mainly showing attenuated hallucinations, which can guide targeted interventions in future care.
View Article and Find Full Text PDF

Background: In children and adolescents compared to adults, clinical high-risk of psychosis (CHR) criteria and symptoms are more prevalent but less psychosis-predictive and less clinically relevant. Based on high rates of non-converters to psychosis, especially in children and adolescents, it was suggested that CHR criteria were: (1) Pluripotential; (2) A transdiagnostic risk factor; and (3) Simply a severity marker of mental disorders rather than specifically psychosis-predictive. If any of these three alternative explanatory models were true, their prevalence should differ between persons with and without mental disorders, and their severity should be associated with functional impairment as a measure of severity.

View Article and Find Full Text PDF

Importance: Diverse models have been developed to predict psychosis in patients with clinical high-risk (CHR) states. Whether prediction can be improved by efficiently combining clinical and biological models and by broadening the risk spectrum to young patients with depressive syndromes remains unclear.

Objectives: To evaluate whether psychosis transition can be predicted in patients with CHR or recent-onset depression (ROD) using multimodal machine learning that optimally integrates clinical and neurocognitive data, structural magnetic resonance imaging (sMRI), and polygenic risk scores (PRS) for schizophrenia; to assess models' geographic generalizability; to test and integrate clinicians' predictions; and to maximize clinical utility by building a sequential prognostic system.

View Article and Find Full Text PDF

Schizophrenia is a complex and chronic neuropsychiatric disorder, with a heritability of around 60-80%. Large (>100 kb) rare (<1%) copy number variants (CNVs) occur more frequently in schizophrenia patients compared to controls. Currently, there are no studies reporting genome-wide CNVs in clinical high risk for psychosis (CHR-P) individuals.

View Article and Find Full Text PDF
Article Synopsis
  • * The study protocol includes a treatment program called "Robin," which combines therapy modules with a smartphone app to support the mental health of CHR adolescents aged 14-18.
  • * This trial aims to evaluate the effectiveness of the Robin approach by comparing it to standard treatment, with outcomes assessed at multiple time points over 3 years, marking it as a pioneering effort in early intervention for psychosis in adolescents.
View Article and Find Full Text PDF

Background: The attenuated positive symptoms syndrome (APSS) is considered an at-risk indicator for psychosis. However, the characteristics and developmental aspects of the combined or enriched risk criteria of APSS and basic symptom (BS) criteria, including self-experienced cognitive disturbances (COGDIS) remain under-researched.

Method: Based on the Structured Interview of Prodromal Syndromes (SIPS), the prevalence of APSS in 13- to 35-year-old individuals seeking help in an early recognition program for schizophrenia and bipolar-spectrum disorders was examined.

View Article and Find Full Text PDF

Background: Neurocognitive deficits are important aspects of schizophrenic disorder because they have a strong impact on social and vocational outcomes. Previously it was assumed that cognitive abilities progressively deteriorate with illness onset. However, recent research results have contradicted this with observations of continuous or even improved performance in individuals at risk for psychosis or manifest schizophrenia.

View Article and Find Full Text PDF

Background: Neurocognitive deficits are important aspects of the schizophrenic disorders because they have a strong impact on social and vocational outcomes. We expanded on previous research by focusing on the neurocognitive profiles of persons at high risk (HR) or ultra-high risk (UHR) for schizophrenic and affective psychoses. Our main aim was to determine whether neurocognitive measures are sufficiently sensitive to predict a group affiliation based on deficits in functional domains.

View Article and Find Full Text PDF